Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • News
  • Our team
  • Our impact
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
Photo of: Alan Staple
Member of the 2022 Expert Review Committee for the Access to Medicine Index

Alan Staple

Alan Staple is a member of the 2022 Expert Review Committee for the Access to Medicine Index.

Alan is Vice President and Head of the Global Markets Team at the Clinton Health Access Initiative (CHAI). His responsibilities include leading negotiations for CHAI agreements with the global pharmaceutical and diagnostics industry and identifying new opportunities and funding partnerships that expand access to life-saving medicines. Alan’s team negotiates agreements to bring new products to market, reduce the costs and prices of existing products, and mobilise funding to implement more cost-effective diagnostic solutions and drug regimens. 

Alan has over 20 years of experience working with multinational pharmaceutical and biotechnology companies to lead business and product development. He has worked to reshape sales policies to emerging markets that have improved access to life-saving medicines, and has negotiated new product introduction and price reduction deals for key health commodities resulting in hundreds of millions of dollars in cost savings.

The Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved